NEDD4L and neoplasm: In prostate and gastric cancers, deficient expression of NEDD4L contributes to a higher tumor grade and poor prognosis,48, 49 suggesting that NEDD4L boosts the TGF‐β/Smad signaling to suppress tumorigenesis.